CONSHOHOCKEN, PA — Cencora (NYSE: COR) has appointed former CVS Health and Bath & Body Works executive Eva C. Boratto as chief financial officer, bringing in a veteran healthcare finance leader as the pharmaceutical services company reaffirmed its fiscal 2026 earnings outlook and long-term growth targets.
Boratto will assume the role of Executive Vice President and Chief Financial Officer on June 29, succeeding James F. Cleary, who previously announced his retirement. Cleary will remain in an advisory role through the end of 2026 to support the leadership transition, the company announced.
The appointment comes as Cencora continues to execute its pharmaceutical-focused growth strategy and maintain guidance for earnings growth despite ongoing uncertainty across healthcare and pharmaceutical markets.
Boratto most recently served as chief financial officer of Bath & Body Works, where she helped oversee a multi-year business transformation that included cost-reduction initiatives and investments in growth initiatives. Prior to that, she spent 12 years at CVS Health, including as executive vice president and chief financial officer, where she helped lead the company’s growth strategy, digital investments, and integration of the Aetna acquisition.
Earlier in her career, Boratto held senior finance positions at Merck & Co., including oversight of the company’s U.S. pharmaceutical business and global vaccines operations.
“Her experience leading complex, global finance organizations and a track record of financial discipline and execution make her the right finance leader for Cencora,” President and Chief Executive Officer Robert P. Mauch stated.
Boratto noted that Cencora’s position within the pharmaceutical supply chain and its growth strategy attracted her to the role.
“Cencora plays a pivotal role at the center of the global pharmaceutical supply chain,” Boratto said. “I look forward to working with Bob and the rest of the leadership team as we build on Cencora’s track record of execution and growth.”
Alongside the leadership announcement, Cencora reaffirmed its fiscal 2026 adjusted diluted earnings-per-share guidance of $17.70 to $17.90. The company had raised the lower end of that range in May following share repurchases.
Cencora also maintained its long-term outlook, including adjusted operating income growth of 7% to 10% and adjusted diluted earnings-per-share growth of 10% to 14%.
Boratto currently serves on the boards of Mars Inc. and United Parcel Service, where she chairs the audit committees of both organizations. She holds an MBA from Drexel University and bachelor’s degrees in accounting and economics from Rutgers University.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.